Biopharmaceuticals
Regulatory
News Release - April 25, 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Source: Gilead Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.